Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
Go back to Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline| (NASDAQ: EWTX) | Delayed: 44.58 +1.06 (2.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.52 | 52 Week High | $ | |||
| Open | $43.71 | 52 Week Low | $ | |||
| Day High | $44.88 | P/E | N/A | |||
| Day Low | $42.50 | EPS | $ | |||
| Volume | 2,018,073 | |||||
